Astellas Pharma (4503N) Q2 2026 Earnings Report
1 Followers
MX:4503N Q2 2026 EPS Results
- Actual EPS
- MXN 6.54
- Consensus EPS
- MXN 7.64
- Beat/Miss
- Missed by -MXN 1.10
- One Year Ago EPS
- MXN 5.20
MX:4503N Q2 2026 Revenue Results
- Actual Revenue
- MXN 74.03B
- Expected Revenue
- MXN 69.62B
- Beat/Miss
- Beat by +MXN 4.40B
- YoY Revenue Growth
- +20.15%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/04/2026
- Time
- Before Open
- Conference Call
- Wednesday, November 4, 2026
MX:4503N Upcoming Earnings
Astellas Pharma's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2026 (Q3) | 7.05- | 6.59 | ― | ― |
| Nov 04, 2026 | 2026 (Q2) | 7.646.54 | 5.2 | 25.92% (+1.35) | |
| Aug 05, 2026 | 2026 (Q1) | 6.369.30 | 4.49 | 107.09% (+4.81) | |
| Apr 27, 2026 | 2025 (Q4) | 3.592.85 | 4.92 | -41.95% (-2.06) | |
| Feb 04, 2026 | 2025 (Q3) | 5.406.59 | -6.41 | 202.73% (+13.00) | |
| Oct 30, 2025 | 2025 (Q2) | 3.505.20 | 2.36 | 120.44% (+2.84) | |
| Jul 30, 2025 | 2025 (Q1) | 2.344.49 | 2.47 | 82.00% (+2.02) | |
| Apr 25, 2025 | 2024 (Q4) | 2.504.92 | -2.18 | 325.50% (+7.10) | |
| Feb 04, 2025 | 2024 (Q3) | 2.88-6.41 | 1.22 | -624.52% (-7.63) | |
| Oct 30, 2024 | 2024 (Q2) | 2.122.36 | -0.09 | 2607.50% (+2.45) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
